COVID-19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Arthritis Rheumatol. 2021 Jun;73(6):1091-1092. doi: 10.1002/art.41671. Epub 2021 Apr 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / virology*
  • COVID-19 / immunology*
  • COVID-19 / virology
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Middle Aged
  • Reinfection
  • SARS-CoV-2 / immunology*

Substances

  • Immunosuppressive Agents